Prior authorization (PA)
The insurer gate on most GLP-1 coverage: documentation that the plan’s criteria (BMI thresholds, comorbidities, sometimes step therapy) are met, submitted before coverage applies, appealable when denied, and expiring on a clock. The clerical battlefield where insurance navigation memberships earn or fail to earn their fee.
Released · Last reviewed · how we verify
Where the term bites in the current data: our dated tirzepatide reads run $129–$399/month all-in and semaglutide $99–$299 (newest reads; NexLife November 20, 2026), and nearly every dollar of those spreads is explained by the vocabulary on this glossary’s pages — memberships inside or outside headline figures, flat versus tiered ladders, prepaid terms dressed as monthly prices, evidence flags separating captures from claims. Reading this market is mostly a matter of knowing which of those words applies to the number in front of you.
Like every entry here, this definition is written against the live dataset rather than in the abstract: when the market moves, the interpolated figures in this glossary move with it on the next build, which is the only way definitions about a repricing market stay true.
See the term in action across the price database and the methodology.